Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA593342
Max Phase: Preclinical
Molecular Formula: C32H45N7O9S2
Molecular Weight: 735.89
Molecule Type: Protein
Associated Items:
ID: ALA593342
Max Phase: Preclinical
Molecular Formula: C32H45N7O9S2
Molecular Weight: 735.89
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)CNS(=O)(=O)c1cccc2c(N(C)C)cccc12)C(=O)O
Standard InChI: InChI=1S/C32H45N7O9S2/c1-18(2)14-22(32(45)46)37-30(43)25-11-7-13-39(25)31(44)21(15-27(33)40)36-29(42)23(17-49)35-28(41)16-34-50(47,48)26-12-6-8-19-20(26)9-5-10-24(19)38(3)4/h5-6,8-10,12,18,21-23,25,34,49H,7,11,13-17H2,1-4H3,(H2,33,40)(H,35,41)(H,36,42)(H,37,43)(H,45,46)/t21-,22-,23-,25-/m0/s1
Standard InChI Key: QSHPKJQBXYJLFM-LCXINAFSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 735.89 | Molecular Weight (Monoisotopic): 735.2720 | AlogP: -0.43 | #Rotatable Bonds: 17 |
Polar Surface Area: 237.41 | Molecular Species: ACID | HBA: 10 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.88 | CX Basic pKa: 4.71 | CX LogP: -1.67 | CX LogD: -3.82 |
Aromatic Rings: 2 | Heavy Atoms: 50 | QED Weighted: 0.10 | Np Likeness Score: -0.66 |
1. Krzysiak AJ, Aditya AV, Hougland JL, Fierke CA, Gibbs RA.. (2010) Synthesis and screening of a CaaL peptide library versus FTase reveals a surprising number of substrates., 20 (2): [PMID:20005705] [10.1016/j.bmcl.2009.11.011] |
Source(1):